|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2003-3-18
|
|
pubmed:abstractText |
The objective of this study was to conduct an economic evaluation of rofecoxib and celecoxib compared with high-dose acetaminophen or ibuprofen with and without misoprostol for patients with symptomatic knee osteoarthritis (OA).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1098-3015
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
144-57
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12641865-Acetaminophen,
pubmed-meshheading:12641865-Analgesics, Non-Narcotic,
pubmed-meshheading:12641865-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:12641865-Cost-Benefit Analysis,
pubmed-meshheading:12641865-Cyclooxygenase Inhibitors,
pubmed-meshheading:12641865-Decision Trees,
pubmed-meshheading:12641865-Humans,
pubmed-meshheading:12641865-Models, Economic,
pubmed-meshheading:12641865-Osteoarthritis, Knee,
pubmed-meshheading:12641865-Outcome Assessment (Health Care),
pubmed-meshheading:12641865-Pain Measurement,
pubmed-meshheading:12641865-Randomized Controlled Trials as Topic
|
|
pubmed:articleTitle |
The cost-effectiveness of acetaminophen, NSAIDs, and selective COX-2 inhibitors in the treatment of symptomatic knee osteoarthritis.
|
|
pubmed:affiliation |
Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
